AntiGenics (AGEN), a biotech firm working on treatments for cancer, autoimmune and infectious diseases, is up $0.11 in the pre-market to $3.10 a share.
ViroPharma (VPHM) is also up in the pre-market. ViroPharma is working on treatments for infectious diseases. Insiders have been buyers on this stock over the past year (see: http://www.marketwatch.com/investing/stock/VPHM/profile?siteid=bigcharts&dist=bigcharts&time=8 )
Biotech is really hot right now, but I will re-iterate that you must be careful. The volatility in this sector cuts both ways!
Subscribe to:
Post Comments (Atom)

No comments:
Post a Comment